4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol has been researched along with Chronic Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eyles, DW; Pond, SM; Stedman, TJ | 1 |
| Chang, WH; Chien, CP; Jann, MW; Liu, HC; Shieh, YS | 1 |
| Cooper, TB; Czobor, P; Volavka, J | 1 |
3 trial(s) available for 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol and Chronic Disease
| Article | Year |
|---|---|
Nonlinear relationship between circulating concentrations of reduced haloperidol and haloperidol: evaluation of possible mechanisms.
Topics: Adolescent; Adult; Aged; Blood Proteins; Chronic Disease; Cytosol; Erythrocytes; Female; Haloperidol; Humans; Hydrogen-Ion Concentration; Ketone Oxidoreductases; Liver; Male; Microsomes, Liver; Middle Aged; Protein Binding; Schizophrenia; Stereoisomerism | 1994 |
Plasma reduced haloperidol/haloperidol ratios in schizophrenic patients treated with high dosages of haloperidol.
Topics: Adult; Chronic Disease; Dose-Response Relationship, Drug; Drug Resistance; Haloperidol; Humans; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia | 1994 |
Plasma drug level and clinical response.
Topics: Chronic Disease; Dose-Response Relationship, Drug; Haloperidol; Humans; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1992 |